Related references
Note: Only part of the references are listed.Recent advances in clinical practice: a systematic review of isolated colonic Crohn's disease: the third IBD?
Sreedhar Subramanian et al.
GUT (2017)
Low Mass Blood Peptides Discriminative of Inflammatory Bowel Disease (IBD) Severity: A Quantitative Proteomic Perspective
Valerie C. Wasinger et al.
MOLECULAR & CELLULAR PROTEOMICS (2016)
Chemokine and cytokine levels in inflammatory bowel disease patients
Udai P. Singh et al.
CYTOKINE (2016)
Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study
Isabelle Cleynen et al.
LANCET (2016)
Serum Proteome Profiles in Stricturing Crohn's Disease: A Pilot Study
Peter Townsend et al.
INFLAMMATORY BOWEL DISEASES (2015)
Disease Activity Assessment in IBD: Clinical Indices and Biomarkers Fail to Predict Endoscopic Remission
James D. Falvey et al.
INFLAMMATORY BOWEL DISEASES (2015)
Immunopathogenesis of IBD: current state of the art
Heitor S. P. de Souza et al.
Nature Reviews Gastroenterology & Hepatology (2015)
Diarrhea in Crohn's Disease: Investigating the Role of the Ileal Hormone Fibroblast Growth Factor 19
Jonathan D. Nolan et al.
JOURNAL OF CROHNS & COLITIS (2015)
Influence of receptor activator of nuclear factor kappa B ligand, osteoprotegerin and interleukin-33 on bone metabolism in patients with long-standing ulcerative colitis
M. Stanislawowski et al.
JOURNAL OF CROHNS & COLITIS (2014)
Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability
Erika Assarsson et al.
PLOS ONE (2014)
Oncostatin M Mediates STAT3-Dependent Intestinal Epithelial Restitution via Increased Cell Proliferation, Decreased Apoptosis and Upregulation of SERPIN Family Members
Florian Beigel et al.
PLOS ONE (2014)
Improving Relapse Prediction in Inflammatory Bowel Disease by Neutrophil-Derived S100A12
Jan Daebritz et al.
INFLAMMATORY BOWEL DISEASES (2013)
Polymorphism in the Retinoic Acid Metabolizing Enzyme CYP26B1 and the Development of Crohn's Disease
Karin Fransen et al.
PLOS ONE (2013)
High-Throughput Multi-Analyte Luminex Profiling Implicates Eotaxin-1 in Ulcerative Colitis
Lori A. Coburn et al.
PLOS ONE (2013)
Improving stability and understandability of genotype-phenotype mapping in Saccharomyces using regularized variable selection in L-PLS regression
Tahir Mehmood et al.
BMC BIOINFORMATICS (2012)
Role of serum cytokine profile in ulcerative colitis assessment
Manuel Luis Rodriguez-Peralvarez et al.
INFLAMMATORY BOWEL DISEASES (2012)
Comparative proteomics analysis of serum proteins in ulcerative colitis patients
Nan Li et al.
MOLECULAR BIOLOGY REPORTS (2012)
Sparse PLS discriminant analysis: biologically relevant feature selection and graphical displays for multiclass problems
Kim-Anh Le Cao et al.
BMC BIOINFORMATICS (2011)
Proteomic technologies for the identification of disease biomarkers in serum: Advances and challenges ahead
Sandipan Ray et al.
PROTEOMICS (2011)
Neutralization of LIGHT ameliorates acute dextran sodium sulphate-induced intestinal inflammation
Michaela Jungbeck et al.
IMMUNOLOGY (2009)
Use of the Noninvasive Components of the Mayo Score to Assess Clinical Response in Ulcerative Colitis
James D. Lewis et al.
INFLAMMATORY BOWEL DISEASES (2008)
Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome
T. Kaiser et al.
GUT (2007)
Association of a CXCL9 polymorphism with pediatric Crohn's disease
Martin Lacher et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Tissue-specific expression of βKlotho and fibroblast growth factor (FGF) receptor Isoforms determines metabolic activity of FGF19 and FGF21
Hiroshi Kurosu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Biomarker discovery for inflammatory bowel disease, using proteomic serum profiling
Marie-Alice Meuwis et al.
BIOCHEMICAL PHARMACOLOGY (2007)
The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss
AR Moschen et al.
GUT (2005)
Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology
Mark S. Silverberg et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2005)
Many chemokines including CCL20/MIP-3α display antimicrobial activity
D Yang et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease
D Foell et al.
GUT (2003)
A common mucosal chemokine (mucosae-associated epithelial chemokine/CCL28) selectively attracts IgA plasmablasts
NH Lazarus et al.
JOURNAL OF IMMUNOLOGY (2003)
Increased presence of cells containing transforming growth factor alpha (TGF-α) in ulcerative colitis, both during active inflammation and in remission
O Grip et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2000)
Share Paper
